Collegium Pharmaceutical, Inc. (COLL)

USD 27.65

(2.18%)

Total Liabilities Summary of Collegium Pharmaceutical, Inc.

  • Collegium Pharmaceutical, Inc.'s latest annual total liabilities in 2023 was 947.87 Million USD , down -3.21% from previous year.
  • Collegium Pharmaceutical, Inc.'s latest quarterly total liabilities in 2024 Q1 was 892.08 Million USD , down -5.89% from previous quarter.
  • Collegium Pharmaceutical, Inc. reported annual total liabilities of 979.28 Million USD in 2022, up 100.2% from previous year.
  • Collegium Pharmaceutical, Inc. reported annual total liabilities of 489.14 Million USD in 2021, up 6.85% from previous year.
  • Collegium Pharmaceutical, Inc. reported quarterly total liabilities of 892.08 Million USD for 2024 Q1, down -5.89% from previous quarter.
  • Collegium Pharmaceutical, Inc. reported quarterly total liabilities of 947.87 Million USD for 2023 Q4, down -5.09% from previous quarter.

Annual Total Liabilities Chart of Collegium Pharmaceutical, Inc. (2023 - 2013)

Historical Annual Total Liabilities of Collegium Pharmaceutical, Inc. (2023 - 2013)

Year Total Liabilities Total Liabilities Growth
2023 947.87 Million USD -3.21%
2022 979.28 Million USD 100.2%
2021 489.14 Million USD 6.85%
2020 457.81 Million USD 109.17%
2019 218.87 Million USD 9.62%
2018 199.66 Million USD 534.08%
2017 31.48 Million USD 16.15%
2016 27.1 Million USD 114.37%
2015 12.64 Million USD -27.03%
2014 17.33 Million USD 402.06%
2013 3.45 Million USD 0.0%

Peer Total Liabilities Comparison of Collegium Pharmaceutical, Inc.

Name Total Liabilities Total Liabilities Difference
Esperion Therapeutics, Inc. 660.79 Million USD -43.446%
Theratechnologies Inc. 98.63 Million USD -860.956%
Safety Shot Inc 3.89 Million USD -24254.221%
Cosmos Health Inc. 30.25 Million USD -3033.216%
Cronos Group Inc. 43.73 Million USD -2067.265%
Ironwood Pharmaceuticals, Inc. 817.36 Million USD -15.967%
Kala Pharmaceuticals, Inc. 48.44 Million USD -1856.604%
Organogenesis Holdings Inc. 181.36 Million USD -422.644%
Universe Pharmaceuticals INC 13.75 Million USD -6791.48%
ProPhase Labs, Inc. 42.54 Million USD -2127.992%
Sonoma Pharmaceuticals, Inc. 8.75 Million USD -10725.457%
Dynavax Technologies Corporation 375.02 Million USD -152.751%
Radius Health, Inc. 804.29 Million USD -17.853%
China SXT Pharmaceuticals, Inc. 9.19 Million USD -10206.808%
Alvotech 1.88 Billion USD 49.65%
Sunshine Biopharma, Inc. 6.13 Million USD -15338.742%
Alpha Teknova, Inc. 38.55 Million USD -2358.761%
Intra-Cellular Therapies, Inc. 136.87 Million USD -592.533%
SCYNEXIS, Inc. 55.45 Million USD -1609.427%
Harrow Health, Inc. 241.75 Million USD -292.085%
Biofrontera Inc. 23.13 Million USD -3996.448%
DURECT Corporation 30.4 Million USD -3017.401%
Supernus Pharmaceuticals, Inc. 487.46 Million USD -94.452%
ANI Pharmaceuticals, Inc. 471.67 Million USD -100.961%
OptiNose, Inc. 194.33 Million USD -387.754%
RedHill Biopharma Ltd. 20.97 Million USD -4418.407%
Aquestive Therapeutics, Inc. 163.9 Million USD -478.309%
Cumberland Pharmaceuticals Inc. 52.51 Million USD -1704.923%
SIGA Technologies, Inc. 57.97 Million USD -1534.911%
Lifecore Biomedical, Inc. 219.8 Million USD -331.245%
Shineco, Inc. 47.6 Million USD -1891.268%
Phibro Animal Health Corporation 725.54 Million USD -30.644%
Procaps Group S.A. 462.06 Million USD -105.139%
TherapeuticsMD, Inc. 14.02 Million USD -6659.927%
Regencell Bioscience Holdings Limited 219.51 Thousand USD -431711.017%
Viatris Inc. 27.21 Billion USD 96.517%
Sunshine Biopharma, Inc. 6.13 Million USD -15338.742%
Rockwell Medical, Inc. 30.88 Million USD -2969.351%
Incannex Healthcare Limited 5.83 Million USD -16158.611%
Aytu BioPharma, Inc. 90.37 Million USD -948.78%
Tilray Brands, Inc. 892.11 Million USD -6.25%
PetIQ, Inc. 645.22 Million USD -46.906%
Silver Spike Investment Corp. 3 Million USD -31392.698%
Neurocrine Biosciences, Inc. 1.01 Billion USD 7.016%
Journey Medical Corporation 56.49 Million USD -1577.688%
Alimera Sciences, Inc. 107.35 Million USD -782.945%
Petros Pharmaceuticals, Inc. 21.31 Million USD -4346.834%
Assertio Holdings, Inc. 148.41 Million USD -538.662%
Shuttle Pharmaceuticals Holdings, Inc. 1.89 Million USD -49894.436%
Embecta Corp. 2.03 Billion USD 53.446%
Cyclo Therapeutics, Inc. 8.49 Million USD -11063.931%
Procaps Group, S.A. 462.06 Million USD -105.139%
PainReform Ltd. 2.69 Million USD -35123.969%
Avadel Pharmaceuticals plc 173.38 Million USD -446.683%
Hempacco Co., Inc. 18.82 Million USD -4935.897%
Talphera, Inc. 6.29 Million USD -14969.587%
Pacira BioSciences, Inc. 704.25 Million USD -34.593%
Alvotech 1.88 Billion USD 49.65%
Lantheus Holdings, Inc. 835.25 Million USD -13.483%
Kamada Ltd. 109.96 Million USD -761.955%
Indivior PLC 1.95 Billion USD 51.422%
Currenc Group, Inc. 177.67 Million USD -433.487%
Evoke Pharma, Inc. 9.64 Million USD -9724.511%
Flora Growth Corp. 17.22 Million USD -5403.873%
Cyclo Therapeutics, Inc. 8.49 Million USD -11063.931%
Evolus, Inc. 209.68 Million USD -352.044%
HUTCHMED (China) Limited 536.38 Million USD -76.715%
Amphastar Pharmaceuticals, Inc. 873.49 Million USD -8.516%
Akanda Corp. 12.66 Million USD -7381.929%